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Abstract
Clostridium diYcile is a well documented
cause of antibiotic associated diarrhoea in
hospitalised patients, but may account for
only approximately 20% of all cases. This
leader reviews the current knowledge and
understanding of the pathogenesis, epide-
miology, and diagnosis of non-food borne
Clostridium perfringens diarrhoea. Al-
though enterotoxigenic C perfringens has
been implicated in some C diYcile nega-
tive cases of antibiotic associated diar-
rhoea, C perfringens enterotoxin detec-
tion methods are not part of the routine
laboratory investigation of such cases.
Testing for C perfringens enterotoxin in
faecal samples from patients with anti-
biotic associated diarrhoea and sporadic
diarrhoea on a routine basis would have
considerable resource implications.
Therefore, criteria for initiating investiga-
tions and optimum laboratory tests need
to be established. In addition, establishing
the true burden of C perfringens anti-
biotic associated diarrhoea is important
before optimum control and treatment
measures can be defined.
(J Clin Pathol 2001;54:748–751)
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Clostridium diYcile is the most commonly iden-
tified pathogen in hospital acquired infective
diarrhoea. However, for most cases (in some
series up to 80%) the organism responsible is
undiagnosed. Staphylococcus aureus and
Clostridium perfringens are the most frequently
cited alternative causes of antibiotic associated
diarrhoea.1 Clostridium perfringens type A is an
important cause of bacterial food poisoning
world wide. There is mounting evidence to
suggest that enterotoxigenic C perfringens
strains can play a role in the aetiology of
diarrhoeal disease distinct from food poison-
ing, including antibiotic associated diarrhoea
and sporadic diarrhoea in humans.2–9 Clostrid-
ium perfringens forms part of the normal human
gut flora in small numbers—up to 103 colony
forming units (cfu)/g. Ingestion of large
numbers of vegetative cells (> 108 enterotoxin
producing organisms) of C perfringens leads to
diarrhoeal illness, as in cases of food borne dis-
ease. The organisms multiply in the small
intestine and sporulate, releasing C perfringens
enterotoxin (CPEnt), which is responsible for
the classic symptoms of food poisoning. Faecal
counts of> 106 C perfringens spores are seen in
symptomatic cases, although similar counts
can be obtained in patients without symptoms.
Experimental diarrhoea has been produced in
human volunteers after oral administration of
CPEnt.10 More recently, CPEnt has been
implicated in the pathogenesis of antibiotic
associated diarrhoea and sporadic diarrhoea.
The aim of this article is to summarise the
available evidence forC perfringens as a cause of
antibiotic associated diarrhoea and provide an
overview of the laboratory methods for diagno-
sis of C perfringens diarrhoeal diseases.
Evidence linking C perfringens to
non-food borne diarrhoeal disease
In 1984, Borriello et al demonstrated that some
C diYcile toxin negative cases of antibiotic
associated diarrhoea were associated with
enterotoxigenic strains of C perfringens.2 In
their study, faecal specimens from patients with
antibiotic associated diarrhoea were examined.
Faecal specimens were screened by tissue
culture assay for CPEnt, and the presence of
enterotoxin was further confirmed by an in
house enzyme linked immunosorbent assay
(ELISA). All the cases of diarrhoea had high
faecal counts (> 106 cfu/g) of C perfringens.
Clostridium perfringens enterotoxin was detected
in the stools of 11 patients with diarrhoea. The
severity, duration, and sporadic nature of the
disease was not characteristic of C perfringens
food poisoning, and most (n = 10) of the
patients developed diarrhoea after antibiotic
treatment. Implicated antibiotics included
penicillins, cephalosporins, trimethoprim, and
cotrimoxazole. Furthermore, CPEnt was not
detected in the stools of patients with inflam-
matory bowel disease (n = 29) and infective
diarrhoea (n = 12), or in patients with normal
stools (n = 16). These findings led the authors
to conclude that enterotoxigenic C perfringens
was a possible cause of antibiotic associated
diarrhoea. Symptoms associated with non-food
borne C perfringens diarrhoeal disease tend to
be protracted and more severe than those of
food poisoning.11 Common symptoms include
abdominal pain and diarrhoea, which are often
accompanied by blood and mucous in the fae-
ces. Borriello and colleagues subsequently
confirmed their earlier findings by extending
the series to 50 patients.3
Samuel et al studied the incidence of
diarrhoea associated with CPEnt by screening
diarrhoeal samples received from both general
practice and hospital patients.4 In addition to
screening for common enteric pathogens, sam-
ples were also tested for the presence of C perf-
ringens and its enterotoxin. Of the 721
diarrhoeal specimens examined, 25 were
shown to contain CPEnt accompanied by high
clostridial counts (> 103 cfu/g). The control
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group samples, consisting of 120 normal stool
specimens, were negative for CPEnt and had
low faecal counts ofC perfringens (< 103 cfu/g).
The study demonstrated a clear association of
C perfringens diarrhoea with elderly hospital-
ised patients, with 22 of 25 of the cases being
hospital inpatients. Most (n = 18) of the
patients had received antibiotics before the
onset of diarrhoea. The antibiotics associated
with the cases were penicillins, cephalosporins,
augmentin, erythromycin, trimethoprim, and
nitrofurantoin. The clinical symptoms devel-
oped on diVerent days over a period of a few
weeks and were not typical of food poisoning. A
more recent study was designed to investigate
the incidence of C perfringens as a cause of
antibiotic associated diarrhoea.5 Hospitalised
patients were assigned to one of the four groups
on the basis of antibiotic usage and diarrhoeal
disease. Patients with infective diarrhoea
caused by other enteric pathogens were ex-
cluded from the study. The control group
(n = 181) comprised patients who had or had
not received antibiotics but had no diarrhoea.
There was no predominant age group or sex.
The stool samples were examined for the pres-
ence of C diYcile and C perfringens toxins.
CPEnt was detected in the faeces of 15 patients
with antibiotic associated diarrhoea, but in
none of the control groups. A further four
patients with diarrhoea had detectable CPEnt,
although there was no association with anti-
biotic treatment. The possibility of cross infec-
tion was suggested on the basis of geographical
clustering, but isolates were not available for
strain typing. However, an epidemiological
investigation carried out elsewhere during an
outbreak ofC perfringens diarrhoea showed that
infecting serotypes were present in the hospital
environment and on the hands of infected
patients.6 Clostridium perfringens serotypes re-
covered from symptomatic patients were
present in 59% of related environmental
samples. Only 9% of samples from areas not
associated with symptomatic patients were
similarly positive. In a study from Japan, C per-
fringens isolates recovered from the faeces of
elderly hospitalised patients with sporadic
diarrhoea were DNA fingerprinted using
pulsed field gel electrophoresis (PFGE).7 Of
the 60 C perfringens isolates examined, 38
shared the same DNA PFGE pattern. Epide-
miological and experimental data suggested
that the diarrhoea was not related to a food
borne outbreak, but was caused by a nosoco-
mial spread of the bacterium.
Sporadic cases of diarrhoea in the commu-
nity have also been caused by C perfringens,
particularly in the elderly population.8 9 In a
study byMpamugo et al, faecal specimens from
isolated sporadic cases of diarrhoea were
examined using a reverse passive latex aggluti-
nation (RPLA) kit (see below) for enterotoxin
detection, and positive results were confirmed
by an in house ELISA.9 Enterotoxin was
detected by ELISA in 43 of 45 specimens that
yielded (in the RPLA kit) a diVerence of two
wells or more between sensitised and control
latex, and in 22 of 56 specimens with a one well
diVerence. Hence, enterotoxin was detected in
65 of the 212 faecal specimens examined.Most
of the enterotoxin positive cases were not asso-
ciated with antibiotic treatment. In some of the
cases, a single point source of food borne
organisms could not be excluded. In addition,
a higher proportion (79%) of the enterotoxin
positive group than the enterotoxin negative
group was resident in the community. The
importance of these findings remains uncer-
tain, but the surprisingly high prevalence of
enterotoxin positive cases raises questions
about the specificity of the detection methods
used. In a recent large study of infectious intes-
tinal disease in the community in England,
CPEnt was found at a much lower prevalence
than in the study by Mpamugo et al, but was
more frequently identified in general prac-
titioner patients (4%) than in the population
cohort (1.2%).12
Thus, evidence supporting a causal role for
C perfringens in non-food borne diarrhoeal dis-
ease includes the presence of enterotoxin in the
faeces of patients with antibiotic associated
diarrhoea or sporadic diarrhoea, as opposed to
asymptomatic individuals or individuals suVer-
ing from infectious intestinal disease caused by
other pathogens.13 14 It might be argued that
patients identified as suVering from C perfrin-
gens antibiotic associated diarrhoea were in fact
cases of food poisoning. Although it is diYcult
to eliminate the possibility of food poisoning
completely, the clinical symptoms described
above were not consistent with those of food
poisoning. There were no case clusters in rela-
tion to time to suggest a common source food
borne outbreak. In a recent study, Collie et al
used restriction fragment length polymorphism
(RFLP) and PFGE to genotype 43 enterotoxi-
genic C perfringens isolates.14 Results of their
study showed that the enterotoxin gene (cpe) is
extrachromosomal in C perfringens isolates as-
sociated with non-food borne diseases in
contrast to the chromosomal enterotoxin gene
present in food poisoning isolates.14 The
importance of this observation is unclear, but it
does strengthen the possibility that C perfrin-
gens antibiotic associated diarrhoea is a distinct
entity. Furthermore, these findings may be
useful for identifying reservoirs of genotypi-
cally distinct subpopulations of enterotoxigenic
C perfringens isolates, which might help in
instituting appropriate preventive measures.
Pathogenesis
There is a paucity of data relating to the patho-
genesis of C perfringens antibiotic associated
diarrhoea. Use of antibiotics in elderly hospi-
talised patients is considered the major risk
factor for acquisition of the disease. It is not
known whether antibiotic exposure primarily
permits the proliferation of small numbers of
resident C perfringens strains or allows acquisi-
tion of enterotoxigenic C perfringens strains—
for example, as a result of impaired colonisa-
tion resistance. The symptoms are mediated by
the production of CPEnt, which is a 35 kDa
polypeptide.14 15 The cpe gene has been cloned,
sequenced, and expressed in Escherischia coli.16
Further studies are required to assess the
extent of genomic diversity among the food
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borne and non-food borne diarrhoeal disease
isolates. These studies may also help to explain
the diVerences in virulence between the geno-
typically distinct subpopulations of enterotoxi-
genic C perfringens isolates. It is widely believed
that sporulation is essential for CPEnt produc-
tion. However, Czeczulin et al reported that
sporulation is not essential for CPEnt produc-
tion, although it does lead to an increased yield
of CPEnt.16 At present, regulation of CPEnt
expression at the molecular level is not well
understood. Studies using gene probe assays
have shown that cpe is present in only 6% of
global C perfringens isolates, whereas 60% of
the isolates associated with food poisoning
were found to be cpe positive by hybridisa-
tion.17 18 These findings were surprising consid-
ering the role of CPEnt in the pathogenesis of
C perfringens food poisoning. Further studies
identified sequence diVerences in cpe regions
that had been used to design some of the DNA
probes.16 These diVerences may well have
interfered with probe hybridisation, resulting in
false negative conclusions about cpe positive
isolates. It is also possible that some of the iso-
lates tested may have been non-enterotoxigenic
normal flora C perfringens isolates because only
single colonies were selected for testing.19 More
recently, use of gene probe assays based on the
cpe sequencing work of Czeczulin and col-
leagues16 found that only a small proportion of
C perfringens isolates carried the cpe gene.20 Of
454 fresh C perfringens isolates from a variety of
sources (animal and environmental), only 16
(3.5%) were polymerase chain reaction (PCR)
positive for cpe.
Diagnosis
The optimum laboratory investigations for
diagnosis of C perfringens antibiotic associated
diarrhoea have not been established, and the
absence of a “gold standard” test hinders
further progress. The tests that have been used
by previous investigators involve the direct
detection of faecal enterotoxin, quantitative
stool cultures for C perfringens, and absence of
other enteric pathogens in stool specimens.
Culture of C perfringens alone does not prove
the diagnosis, particularly in light of the high
numbers of asymptomatic carriers in the insti-
tutional setting.21 22 However, stool cultures
provide the isolates from which useful data can
be obtained (see below).
Clostridium perfringens can be found in small
numbers (up to 103 cfu/g) in the faeces of
healthy individuals.4 However, there have been
reports of high faecal counts of C perfringens
(> 107 cfu/g) in specimens obtained from
healthy geriatric patients.21 22 In a study carried
out by Yamagishi et al,21 persistently high num-
bers of C perfringens were found in the faeces of
Japanese geriatric patients (five of 30). Stringer
et al studied faecal carriage of C perfringens in
younger and elderly long stay hospital patients
and found similar results in five of 21 elderly
patients (counts > 107 cfu/g).22 However, the
younger long stay patients in the same hospital
had faecal counts in the range of 103 to 104 cfu/
g. These findings are in contrast to the findings
reported by Samuel et al.4 None of the control
group samples (n = 120) in their study, includ-
ing those from healthy elderly patients, had
faecal counts of C perfringens > 103 cfu/g.
These conflicting results may be the result of
the low numbers of patients recruited in the
studies conducted by Yamagishi and col-
leagues21 and Stringer et al.22 Therefore, it is
essential to detect enterotoxin in faecal samples
when attempting to confirmC perfringens as the
cause of illness.23 A large number of methods
including ELISA, RPLA, and tissue culture
assays have been used for the detection of
C perfringens enterotoxin in faeces, but each has
limitations.24 25 Tissue culture assay, using vero
cells, is least sensitive (40 ng enterotoxin/g fae-
ces) and reproducible among toxin detection
methods.24 An in house ELISA available at the
Public Health Laboratory Service central food
hygiene laboratory has been suggested as the
gold standard among toxin detection methods
on the basis of its sensitivity (5 ng enterotoxin/
g), specificity, and reproducibility.13 24 The
RPLA kit (Oxoid, Basingstoke, UK) has been
shown to be both sensitive and reproducible,
but non-specific interference by faecal matter
has been reported. In addition, some authors
have reported that this method has relatively
poor sensitivity (50–100 ng enterotoxin/g).25
Recently, a new C perfringens enterotoxin
ELISA kit (produced by TechLab; distributed
by BioConnections, Leeds, UK) has become
commercially available. However, data com-
paring this ELISA with the methods referred to
above are not available. In one study,5 detection
of enterotoxin alone using the new ELISA kit
was used as the laboratory diagnostic criterion
for inpatients with antibiotic associated diar-
rhoea. A study undertaken at our hospital using
the commercial ELISA kit found that 15% of
faecal specimens from patients with antibiotic
associated diarrhoea were CPEnt positive (NJ
Ransome et al, Abstracts of 38th Interscience
Conference on Antimicrobial Agents and
Chemotherapy, 1998, San Diego. Abstract K
126). This figure is very similar to the results of
a previous study.5 Ten percent of isolates from
ELISA negative faecal specimens were cpe
positive by PCR (NJ Ransome et al, Abstracts
of 38th Interscience Conference on Anti-
microbial Agents and Chemotherapy, 1998,
San Diego. Abstract K 126). It is possible that
cpe positive C perfringens isolates produced
enterotoxin in vivo to cause disease, but there
were insuYcient faecal concentrations of
CPEnt to be detected by ELISA, thus generat-
ing false negative results. This could be
compounded by the collection of samples late
after the onset of illness, because there is
evidence that maximum excretion of entero-
toxin occurs early in the food borne diarrhoeal
illness.13 Further studies are required to
confirm that these findings hold true in cases of
non-food borne diarrhoeal illness, and to
determine the importance of these preliminary
findings. In addition 13 of 19 presumptive
C perfringens isolates from ELISA positive fae-
cal specimens were cpe negative (NJ Ransome
et al, Abstracts of 38th Interscience Conference
on Antimicrobial Agents and Chemotherapy,
1998, San Diego. Abstract K 126). It is possible
750 Modi,Wilcox
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that these specimens contained very low num-
bers of cpe positive organisms and conse-
quently tested isolates were PCR negative.
Furthermore,C perfringens isolates can lose the
enterotoxin gene during subculture.26
Gene probe or PCR assays can be used to
determine the enterotoxigenicity of C perfrin-
gens isolates and thereby avoid the problems
associated with culture, and subsequent en-
terotoxin production in vitro, and the inherent
limitations of toxin detection methods. In an
attempt to overcome these potential problems,
direct detection of cpe in primary faecal speci-
mens by PCR was undertaken in our hospital,
using a PCR protocol based on that of Kokai-
Kun et al.20 However, all tested faecal samples,
including the specimens spiked with entero-
toxigenic C perfringens reference strains, pro-
duced negative results, despite universal bacte-
rial DNA primers yielding positive
amplification reactions. It is assumed that the
high concentration of background bacterial
DNA in stool samples may have interfered with
amplification. However, elsewhere PCR assays
have been used successfully for the direct
detection of enterotoxin genes in faeces.27 28 For
example, Saito et al successfully used the
supernatant of sporulation cultures of faeces as
template DNA to detect cpe by PCR.28 Further
work is needed to overcome the problems asso-
ciated with the extraction and amplification of
C perfringensDNA from stool samples. Resolu-
tion of this problem could render PCR an
important tool for understanding more about
C perfringens diarrhoeal diseases.
Conclusion
It has been 17 years since Borriello et al first
demonstrated the role of enterotoxigenic C per-
fringens in the aetiology of antibiotic associated
diarrhoea or sporadic diarrhoea, but only
limited further research has followed. Current
knowledge and understanding of the pathogen-
esis, epidemiology, and diagnosis of C perfrin-
gens non-food borne diarrhoeal illness is based
on the results of a few published studies, and
partly on the extrapolation of data obtained
from C perfringens food poisoning outbreaks.
Clostridium diYcile is a well documented cause
of antibiotic associated diarrhoea in hospital-
ised patients, but may account for only
approximately 20% of all cases.29 Although
enterotoxigenic C perfringens has been impli-
cated in some of these C diYcile negative cases
of antibiotic associated diarrhoea, CPEnt
detection methods are not part of the routine
laboratory investigation of such cases. The cri-
teria for initiating investigations and optimum
laboratory tests need to be established. In
addition, any diagnostic method used should
be rapid, easy to perform, and inexpensive. The
performance of the commercial ELISA kit
needs to be further evaluated against other
methods before being adopted by routine diag-
nostic laboratories. Testing for C perfringens
enterotoxin in faecal samples from patients
with antibiotic associated diarrhoea and spo-
radic diarrhoea on a routine basis would have
considerable resource implications. In addi-
tion, establishing the true burden of C perfrin-
gens antibiotic associated diarrhoea is impor-
tant before optimum control and treatment
measures can be defined.
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